Detalhe da pesquisa
1.
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
Lancet
; 403(10421): 31-43, 2024 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048793
2.
Pretreatment systemic inflammatory markers predict survival in endometrial cancer: A Japanese Gynecologic Oncology Group 2043 exploratory data analysis.
Gynecol Oncol
; 181: 46-53, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113633
3.
Olaparib maintenance therapy for platinum-sensitive relapsed ovarian cancer at a single institution: A retrospective study.
J Obstet Gynaecol Res
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38742699
4.
Validation of RNA Extraction Methods and Suitable Reference Genes for Gene Expression Studies in Developing Fetal Human Inner Ear Tissue.
Int J Mol Sci
; 25(5)2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38474154
5.
Comprehensive genetic screening for vascular Ehlers-Danlos syndrome through an amplification-based next-generation sequencing system.
Am J Med Genet A
; 191(1): 37-51, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36189931
6.
Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group.
Gynecol Oncol
; 176: 82-89, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37478616
7.
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer.
Gynecol Oncol
; 177: 20-31, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37625235
8.
Phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear cell carcinoma Kansai Clinical Oncology Group-G1601.
Anticancer Drugs
; 34(7): 857-865, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36729915
9.
Current status of vulvar cancer in Japan: analysis of the Japanese Gynecologic Oncology Group nationwide survey study.
Jpn J Clin Oncol
; 53(11): 1003-1008, 2023 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37551024
10.
Current status and molecular biology of human papillomavirus-independent gastric-type adenocarcinoma of the cervix.
J Obstet Gynaecol Res
; 49(4): 1106-1113, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36759334
11.
Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE-826.
Cancer Sci
; 113(11): 3877-3887, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35792064
12.
Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial: A randomized phase II study for advanced endometrial carcinoma.
Cancer Sci
; 113(5): 1693-1701, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35218673
13.
The genetic etiology of hearing loss in Japan revealed by the social health insurance-based genetic testing of 10K patients.
Hum Genet
; 141(3-4): 665-681, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599366
14.
Prevalence and clinical features of autosomal dominant and recessive TMC1-associated hearing loss.
Hum Genet
; 141(3-4): 929-937, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34523024
15.
Variants in CDH23 cause a broad spectrum of hearing loss: from non-syndromic to syndromic hearing loss as well as from congenital to age-related hearing loss.
Hum Genet
; 141(3-4): 903-914, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35020051
16.
Human deafness-associated variants alter the dynamics of key molecules in hair cell stereocilia F-actin cores.
Hum Genet
; 141(3-4): 363-382, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34232383
17.
Detailed clinical features and genotype-phenotype correlation in an OTOF-related hearing loss cohort in Japan.
Hum Genet
; 141(3-4): 865-875, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34536124
18.
Genetic background in late-onset sensorineural hearing loss patients.
J Hum Genet
; 67(4): 223-230, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34824372
19.
Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: An open-label multicenter phase II trial (JGOG1079).
Gynecol Oncol
; 165(3): 413-419, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35487773
20.
Surgical skill and oncological outcome of laparoscopic radical hysterectomy: JGOG1081s-A1, an ancillary analysis of the Japanese Gynecologic Oncology Group Study JGOG1081.
Gynecol Oncol
; 165(2): 293-301, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35221133